Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN(R) in Combination … – MarketWatch (press release)
Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN(R) in Combination …MarketWatch (press release)The trial is designed to enroll a total of 100 patients in North America, who will be randomized to one of two treatment arms: ZEVALIN + rituxim…
